Abbott DBS Post-Market Study of Outcomes for Indications Over Time

  • End date
    Sep 12, 2030
  • participants needed
  • sponsor
    Abbott Medical Devices
Updated on 12 July 2021
parkinson's disease
deep brain stimulation
brain stimulation
motor symptoms
essential tremor


The purpose of this international study is to evaluate long-term safety and effectiveness of Abbott deep brain stimulation (DBS) systems for all indications, including Parkinson's disease, essential tremor or other disabling tremor and dystonia.


ADROIT is an international, prospective, multicenter, observational, post-market study intended to collect worldwide long-term safety and effectiveness data on subjects implanted with market-released Abbott DBS systems in routine clinical practice.

Subjects will be followed for 5 years after the initial programming visit.

Condition Orofacial Dyskinesia, Dystonia, Tremor, Essential Tremor, Dystonia, Parkinson's disease, Dystonias, movement disorder, parkinson's, parkinson disease, shakes, shake, movement disorders, primary dystonia
Treatment Deep Brain Stimulation (DBS)
Clinical Study IdentifierNCT04071847
SponsorAbbott Medical Devices
Last Modified on12 July 2021


Yes No Not Sure

Inclusion Criteria

Subject is scheduled for a new implant or IPG device replacement surgery with a market-released Abbott DBS system within 180 days
Subject, or a legally acceptable representative, must provide written informed consent prior to any study-related procedure

Exclusion Criteria

Subject is currently enrolled or plans to enroll in an investigational study that may confound the results of this study
Subject has anatomic or comorbid conditions, or other medical, social, or psychological conditions that, in the investigator's opinion, could limit the subject's ability to participate in the study or to comply with follow-up requirements, or impact the scientific soundness of the study results
Study center is located in the United States, and indication for DBS implant is not Parkinson's disease or disabling tremor
Study center is located in the United States, and the intended lead implant location is not at, or in close proximity to, the STN, GPi, or VIM thalamus
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note